These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 22800288)
1. Targeting claudin-4 in human pancreatic cancer. Kojima T; Kyuno D; Sawada N Expert Opin Ther Targets; 2012 Sep; 16(9):881-7. PubMed ID: 22800288 [TBL] [Abstract][Full Text] [Related]
2. Effects of Clostridium perfringens enterotoxin via claudin-4 on normal human pancreatic duct epithelial cells and cancer cells. Yamaguchi H; Kojima T; Ito T; Kyuno D; Kimura Y; Imamura M; Hirata K; Sawada N Cell Mol Biol Lett; 2011 Sep; 16(3):385-97. PubMed ID: 21573709 [TBL] [Abstract][Full Text] [Related]
3. Regulation of tight junctions in human normal pancreatic duct epithelial cells and cancer cells. Kojima T; Sawada N Ann N Y Acad Sci; 2012 Jun; 1257():85-92. PubMed ID: 22671593 [TBL] [Abstract][Full Text] [Related]
4. Protein kinase Cα inhibitor enhances the sensitivity of human pancreatic cancer HPAC cells to Clostridium perfringens enterotoxin via claudin-4. Kyuno D; Kojima T; Ito T; Yamaguchi H; Tsujiwaki M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N Cell Tissue Res; 2011 Dec; 346(3):369-81. PubMed ID: 22160590 [TBL] [Abstract][Full Text] [Related]
5. Claudin-4-targeted optical imaging detects pancreatic cancer and its precursor lesions. Neesse A; Hahnenkamp A; Griesmann H; Buchholz M; Hahn SA; Maghnouj A; Fendrich V; Ring J; Sipos B; Tuveson DA; Bremer C; Gress TM; Michl P Gut; 2013 Jul; 62(7):1034-43. PubMed ID: 22677720 [TBL] [Abstract][Full Text] [Related]
6. Clostridium perfringens enterotoxin as a potential drug for intravesical treatment of bladder cancer. Gabig TG; Waltzer WC; Whyard T; Romanov V Biochem Biophys Res Commun; 2016 Sep; 478(2):887-92. PubMed ID: 27520378 [TBL] [Abstract][Full Text] [Related]
7. Cytotoxicity of Clostridium perfringens enterotoxin depends on the conditions of claudin-4 in ovarian carcinoma cells. Tanaka S; Aoyama T; Ogawa M; Takasawa A; Murata M; Osanai M; Saito T; Sawada N Exp Cell Res; 2018 Oct; 371(1):278-286. PubMed ID: 30142326 [TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of claudin-18 via specific protein kinase C signaling pathways and modification of DNA methylation in human pancreatic cancer cells. Ito T; Kojima T; Yamaguchi H; Kyuno D; Kimura Y; Imamura M; Takasawa A; Murata M; Tanaka S; Hirata K; Sawada N J Cell Biochem; 2011 Jul; 112(7):1761-72. PubMed ID: 21381080 [TBL] [Abstract][Full Text] [Related]
9. Tissue distribution and safety evaluation of a claudin-targeting molecule, the C-terminal fragment of Clostridium perfringens enterotoxin. Li X; Saeki R; Watari A; Yagi K; Kondoh M Eur J Pharm Sci; 2014 Feb; 52():132-7. PubMed ID: 24231339 [TBL] [Abstract][Full Text] [Related]
10. Transcriptional control of tight junction proteins via a protein kinase C signal pathway in human telomerase reverse transcriptase-transfected human pancreatic duct epithelial cells. Yamaguchi H; Kojima T; Ito T; Kimura Y; Imamura M; Son S; Koizumi J; Murata M; Nagayama M; Nobuoka T; Tanaka S; Hirata K; Sawada N Am J Pathol; 2010 Aug; 177(2):698-712. PubMed ID: 20566751 [TBL] [Abstract][Full Text] [Related]
11. Preparation of a claudin-targeting molecule using a C-terminal fragment of Clostridium perfringens enterotoxin. Ebihara C; Kondoh M; Hasuike N; Harada M; Mizuguchi H; Horiguchi Y; Fujii M; Watanabe Y J Pharmacol Exp Ther; 2006 Jan; 316(1):255-60. PubMed ID: 16183701 [TBL] [Abstract][Full Text] [Related]
12. Targeting tight junctions during epithelial to mesenchymal transition in human pancreatic cancer. Kyuno D; Yamaguchi H; Ito T; Kono T; Kimura Y; Imamura M; Konno T; Hirata K; Sawada N; Kojima T World J Gastroenterol; 2014 Aug; 20(31):10813-24. PubMed ID: 25152584 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of claudin-3 and claudin-4 receptors in uterine serous papillary carcinoma: novel targets for a type-specific therapy using Clostridium perfringens enterotoxin (CPE). Santin AD; Bellone S; Marizzoni M; Palmieri M; Siegel ER; McKenney JK; Hennings L; Comper F; Bandiera E; Pecorelli S Cancer; 2007 Apr; 109(7):1312-22. PubMed ID: 17326053 [TBL] [Abstract][Full Text] [Related]
14. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Michl P; Buchholz M; Rolke M; Kunsch S; Löhr M; McClane B; Tsukita S; Leder G; Adler G; Gress TM Gastroenterology; 2001 Sep; 121(3):678-84. PubMed ID: 11522752 [TBL] [Abstract][Full Text] [Related]
15. A novel tumor-targeted therapy using a claudin-4-targeting molecule. Saeki R; Kondoh M; Kakutani H; Tsunoda S; Mochizuki Y; Hamakubo T; Tsutsumi Y; Horiguchi Y; Yagi K Mol Pharmacol; 2009 Oct; 76(4):918-26. PubMed ID: 19638534 [TBL] [Abstract][Full Text] [Related]
16. Overexpression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in uterine carcinosarcomas. Santin AD; Bellone S; Siegel ER; McKenney JK; Thomas M; Roman JJ; Burnett A; Tognon G; Bandiera E; Pecorelli S Clin Cancer Res; 2007 Jun; 13(11):3339-46. PubMed ID: 17545541 [TBL] [Abstract][Full Text] [Related]
17. Expression of Clostridium perfringens enterotoxin receptors claudin-3 and claudin-4 in prostate cancer epithelium. Long H; Crean CD; Lee WH; Cummings OW; Gabig TG Cancer Res; 2001 Nov; 61(21):7878-81. PubMed ID: 11691807 [TBL] [Abstract][Full Text] [Related]
18. HDAC gene expression in pancreatic tumor cell lines following treatment with the HDAC inhibitors panobinostat (LBH589) and trichostatine (TSA). Mehdi O; Françoise S; Sofia CL; Urs G; Kevin Z; Bernard S; Igor S; Anabela CD; Dominique L; Eric M; Ali O Pancreatology; 2012; 12(2):146-55. PubMed ID: 22487525 [TBL] [Abstract][Full Text] [Related]
19. Claudin-4-targeting of diphtheria toxin fragment A using a C-terminal fragment of Clostridium perfringens enterotoxin. Kakutani H; Kondoh M; Saeki R; Fujii M; Watanabe Y; Mizuguchi H; Yagi K Eur J Pharm Biopharm; 2010 Jun; 75(2):213-7. PubMed ID: 20226859 [TBL] [Abstract][Full Text] [Related]